The Global Cell Surface Markers Market was
valued at USD 13.2 billion in 2012 and is expected to grow at a CAGR of 8.1%
from 2013 to 2019, to reach an estimated value of USD 23.03 billion in 2019.
Cell surface markers are expressed on the
surface of cells and function as identifiers of certain type of cells. The
presence of cell markers also assists in the determination of cell type
expression of specific receptors vital for biological response. Cell surface
marker analysis is also essential in determination of experimental drug or
ligand response. Rapid development in healthcare technology, growing preference
for reduction of healthcare expenditure by lowering the cost of diagnosis,
reduction in the risk of misdiagnosis, rapid and efficient decision making for
therapies for specific diseases are some of the major factors which support the
growing acceptance of cell surface marker analysis worldwide.
Browse the full report with complete TOC athttp://www.transparencymarketresearch.com/cell-surface-markers-market.html
On the other hand, complexity of high-end
flow cytometers and high cost of reagents, controls and analysis systems result
into lowering the adoption of sophisticated cell marker analysis solutions,
particularly in economically lagged countries. Increased market consolidation,
simplification of analysis products, cost containment of such products and
introduction of cheaper products in less developed markets are the major market
strategies which are being adopted by the existing and emerging market players
to sustain the cell surface markers market.
The global cell surface markers market can
be categorized into instruments and reagents, kits and controls used for cell
marker analysis. Flow cytometers and hematology analyzers are the prime cell
marker analysis equipment used. Flow cytometry is the most prominently used
tool for cell marker analysis. Availability of a wide range of flow cytometers
and their efficacy in both research and drug discovery are the major factors
driving the Transparency Market Research demand for flow cytometers. It is
expected that the global market for flow cytometers will grow at a CAGR of more
than 8% from 2013 to 2019 with a cumulative installed base of approximately
over 85,000 units by 2019.
Disease diagnosis and identification and
research and drug discovery are the two prime application areas of cell surface
marker analysis. Cell markers analysis is essential in drug discovery and its
use in R&D by pharmaceutical manufacturers and researchers widespread. Thus
in terms of allocations, drug discovery and research segment is expected to
dominate the global cell surface markers during the given period of forecast.
Browse the full
report with complete TOC athttp://www.transparencymarketresearch.com/cell-surface-markers-market.html
No comments:
Post a Comment